UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response (<pCR) After Primary Chemotherapy

The oncologist (Dayton, Ohio), 2009-11, Vol.14 (11), p.1051-1060

2009

Volltextzugriff (PDF)

Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?

Thyroid (New York, N.Y.), 2015-11, Vol.25 (11), p.1255-1261

2015

Volltextzugriff (PDF)

Undescribed Case of Necrotic Ulcerative Amyopathic Dermatomyositis in Bone Metastatic Breast Cancer

The breast journal, 2008-11, Vol.14 (6), p.591-592

2008

Volltextzugriff (PDF)

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

Journal of translational medicine, 2016-10, Vol.14 (1), p.292-292, Article 292

2016

Volltextzugriff (PDF)

Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib

Thyroid (New York, N.Y.), 2016-09, Vol.26 (9), p.1336-1337

2016

Volltextzugriff (PDF)

Thyroid dysfunction and autoimmunity in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as a potential clinical biomarker of response

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15588-e15588

2015

Volltextzugriff (PDF)

Inflammatory breast cancer in Italy

Cancer, 2010-06, Vol.116 (S11), p.2736-2740

2010

Volltextzugriff (PDF)

Meeting psychosocial and health information needs to ensure quality of cancer care in outpatients

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2017-08, Vol.29, p.98-105

2017

Volltextzugriff (PDF)

The panitumumab with FOLFOX4 in metastatic gastric or gastroesophageal junction adenocarcinoma (mGA) - VEGA trial. Efficacy and safety outcomes of a phase II S.I.C.O.G. study

Annals of oncology, 2017-06, Vol.28, p.iii40-iii40

2017

Volltextzugriff (PDF)

Inflammatory Breast Cancer in Italy: Epidemiological and Clinical Aspects

Cancer, 2010-06, Vol.116 (11), p.2736-2740

2010

Volltextzugriff (PDF)

Prolonged (PI) vs short-term irinotecan (STI) administration: The Martha trial—A SICOG (Southern Italy Cooperative Oncology Group) randomized phase III study in the first-line setting of metastatic colorectal cancer (mCRC) patients (pts)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3552-3552

2017

Volltextzugriff (PDF)

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

Journal of translational medicine, 2012-08, Vol.10 (1), p.178-178, Article 178

2012

Volltextzugriff (PDF)

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

Journal of translational medicine, 2014-09, Vol.12 (1), p.272-272, Article 272

2014

Volltextzugriff (PDF)

Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer

Oncotarget, 2018-01, Vol.9 (2), p.2876-2886

2018

Volltextzugriff (PDF)

Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A+C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9614-9614

2013

Volltextzugriff (PDF)

Targeting insulin-like growth factor type 1 receptor in cancer therapy

Targeted oncology, 2009-12, Vol.4 (4), p.255-266

2009

Volltextzugriff (PDF)

Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia

Oncology letters, 2014-04, Vol.7 (4), p.948-952

2014

Volltextzugriff (PDF)

Genome-wide association study of susceptibility loci for breast cancer in Sardinian population

BMC cancer, 2015-05, Vol.15 (1), p.383-383, Article 383

2015

Volltextzugriff (PDF)

Heterogeneous prevalence of somatic mutations in KRAS , BRAF , and PIK3CA genes among patients with colorectal carcinoma: Clues from Sardinia

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14094-e14094

2012

Volltextzugriff (PDF)

Molecular alterations in key-regulator genes among patients with T4 breast carcinoma

BMC cancer, 2010-08, Vol.10 (1), p.458-458, Article 458

2010

Volltextzugriff (PDF)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma

Oncology letters, 2016-08, Vol.12 (2), p.1415-1421

2016

Volltextzugriff (PDF)

Jejunal Obstruction Caused by Metastasis from an Undiagnosed Breast Cancer: A Case Report

Tumori, 2012-05, Vol.98 (3), p.89-91

2012

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Humans
(20)
Female
(19)
Oncology
(15)
Middle Aged
(13)
Adult
(10)
Aged
(10)
Male
(10)
Treatment Outcome
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Genetic Aspects
(6)
Italy
(6)
Breast Neoplasms - Pathology
(5)
Cancer
(5)
Colorectal Cancer
(5)
Analysis
(4)
Biological And Medical Sciences
(4)
Breast Cancer
(4)
Breast Neoplasms - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response (<pCR) After Primary Chemotherapy

Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?

Undescribed Case of Necrotic Ulcerative Amyopathic Dermatomyositis in Bone Metastatic Breast Cancer

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib

Thyroid dysfunction and autoimmunity in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as a potential clinical biomarker of response

Inflammatory breast cancer in Italy

Meeting psychosocial and health information needs to ensure quality of cancer care in outpatients

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

The panitumumab with FOLFOX4 in metastatic gastric or gastroesophageal junction adenocarcinoma (mGA) - VEGA trial. Efficacy and safety outcomes of a phase II S.I.C.O.G. study

Inflammatory Breast Cancer in Italy: Epidemiological and Clinical Aspects

Prolonged (PI) vs short-term irinotecan (STI) administration: The Martha trial—A SICOG (Southern Italy Cooperative Oncology Group) randomized phase III study in the first-line setting of metastatic colorectal cancer (mCRC) patients (pts)

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer

Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A+C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study

Targeting insulin-like growth factor type 1 receptor in cancer therapy

Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia

Genome-wide association study of susceptibility loci for breast cancer in Sardinian population

Heterogeneous prevalence of somatic mutations in KRAS , BRAF , and PIK3CA genes among patients with colorectal carcinoma: Clues from Sardinia

Molecular alterations in key-regulator genes among patients with T4 breast carcinoma

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma

Jejunal Obstruction Caused by Metastasis from an Undiagnosed Breast Cancer: A Case Report

Suchergebnisse filtern